Drug

Could an Ancient Drug Help Fight Severe COVID-19?

By Amy Norton
       
       HealthDay Reporter

WEDNESDAY, April 22, 2020 (HealthDay News) — As researchers hunt for means to treat serious COVID-19 bacterial infections, a new demo will ask no matter whether an outdated arthritis drug can reduce severe complications in the initial place.

The medicine, named colchicine, is an oral anti-inflammatory that has prolonged been prescribed for gout, a kind of arthritis. Its record goes again countless numbers of many years, and the drug was initial sourced from the autumn crocus flower.

Medical practitioners also often use colchicine to treat pericarditis, where by the sac all-around the coronary heart results

Read More

COVID-19 Slows Drug Studies, Curbs Clinical Trials

March 31, 2020 — When individuals with terminal diagnoses run out of hope, they typically change to clinical trials for a single more “Hail Mary pass” at a prosperous treatment method or treatment.

Many in this scenario have been exceptionally anxious more than the last couple weeks, with COVID-19 fears on prime of the stress and anxiety of owning a deadly illness. Then they began to worry that their clinical trial would be canceled.

The very good news is that most firms and scientists seem to be continuing trials for lifestyle-threatening situations. The poor news: Most experiments not thought of

Read More

First Coronavirus-Related Drug Shortage Reported in U.S.

Latest Infectious Disease News

FRIDAY, Feb. 28, 2020 (HealthDay News) — The initially coronavirus-joined drug lack in the United States has been documented by the Foods and Drug Administration.

The agency explained the maker of an unnamed drug that was not long ago extra to the Food and drug administration Drug Shortages checklist blamed the issue on the novel coronavirus, CNN documented.

Particularly, the lack is due to an concern with the production of an lively pharmaceutical component utilised in the drug, according to the company.

The Food and drug administration has warned that this kind of shortages could arise

Read More

Drug Shows Promise Vs. Aggressive Breast Cancer

By Amy Norton
HealthDay Reporter

WEDNESDAY, Feb. 26, 2020 (HealthDay Information) — The immunotherapy drug Keytruda could provide a new procedure choice to gals with an aggressive sort of breast cancer, a medical demo suggests.

The analyze uncovered that for gals with “triple-damaging” breast cancer, adding Keytruda to standard chemotherapy enhanced their odds of responding.

And in the months afterward, gals handled with the drug were a lot less possible to see their cancer arrive back.

The conclusions are encouraging in a illness that is demanding to take care of, claimed

Read More